169 related articles for article (PubMed ID: 10773252)
1. Tumor bed cyst formation after BCNU wafer implantation: report of two cases.
Engelhard HH
Surg Neurol; 2000 Mar; 53(3):220-4. PubMed ID: 10773252
[TBL] [Abstract][Full Text] [Related]
2. Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
McGirt MJ; Villavicencio AT; Bulsara KR; Friedman HS; Friedman AH
J Neurosurg; 2002 May; 96(5):941-5. PubMed ID: 12005403
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Symptomatic Cyst Formation after BCNU Wafer Implantation for Glioblastoma].
Nakase K; Matsuda R; Nishimura F; Nakamura M; Motoyama Y; Park YS; Nakase H
No Shinkei Geka; 2015 Aug; 43(8):747-52. PubMed ID: 26224470
[TBL] [Abstract][Full Text] [Related]
4. Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series.
Subach BR; Witham TF; Kondziolka D; Lunsford LD; Bozik M; Schiff D
Neurosurgery; 1999 Jul; 45(1):17-22; discussion 22-3. PubMed ID: 10414561
[TBL] [Abstract][Full Text] [Related]
5. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
Engelhard HH
Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
[TBL] [Abstract][Full Text] [Related]
6. The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Del Moro G; Rotilio A; Manara R; Paola Gardiman M; Denaro L; d'Avella D; Scienza R
Acta Neurochir (Wien); 2010 Nov; 152(11):1923-31. PubMed ID: 20703889
[TBL] [Abstract][Full Text] [Related]
7. The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
Hasegawa Y; Iuchi T; Sakaida T; Yokoi S; Kawasaki K
J Clin Neurosci; 2016 Sep; 31():67-71. PubMed ID: 27430412
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.
Shibahara I; Hanihara M; Watanabe T; Dan M; Sato S; Kuroda H; Inamura A; Inukai M; Hara A; Yasui Y; Kumabe T
J Neurooncol; 2018 Apr; 137(2):417-427. PubMed ID: 29468445
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
[TBL] [Abstract][Full Text] [Related]
10. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma.
Shibahara I; Miyasaka K; Sekiguchi A; Ishiyama H; Inukai M; Yasui Y; Watanabe T; Sato S; Hide T; Kumabe T
J Clin Neurosci; 2021 Apr; 86():202-210. PubMed ID: 33775329
[TBL] [Abstract][Full Text] [Related]
12. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Recurrence After Resection of Malignant Gliomas With BCNU Wafer Implants: Retrospective Review in a Single Institution.
Shimato S; Nishizawa T; Ohshima T; Imai T; Goto S; Yamamoto T; Kato K
World Neurosurg; 2016 Jun; 90():340-347. PubMed ID: 26960286
[TBL] [Abstract][Full Text] [Related]
14. Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas.
Roux A; Ammar H; Moiraghi A; Peeters S; Baroud M; Zah-Bi G; Benzakoun J; Parraga E; Oppenheim C; Benevello C; Chretien F; Varlet P; Dhermain F; Dezamis E; Zanello M; Pallud J
Neurosurg Rev; 2022 Apr; 45(2):1501-1511. PubMed ID: 34651215
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
[TBL] [Abstract][Full Text] [Related]
16. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.
Sabel M; Giese A
Curr Med Res Opin; 2008 Nov; 24(11):3239-57. PubMed ID: 18940042
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.
Shapira-Furman T; Serra R; Gorelick N; Doglioli M; Tagliaferri V; Cecia A; Peters M; Kumar A; Rottenberg Y; Langer R; Brem H; Tyler B; Domb AJ
J Control Release; 2019 Feb; 295():93-101. PubMed ID: 30605703
[TBL] [Abstract][Full Text] [Related]
19. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
[TBL] [Abstract][Full Text] [Related]
20. Polymeric drug delivery for the treatment of glioblastoma.
Wait SD; Prabhu RS; Burri SH; Atkins TG; Asher AL
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii9-ii23. PubMed ID: 25746091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
